World's Best Scientists 2026 revealed!
Christopher J. O'Donnell

Christopher J. O'Donnell

Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2023

D-Index & Metrics

Best Scientists

D-Index
190
Citations
190122
World Ranking
416
National Ranking
277

Medicine

D-Index
191
Citations
180595
World Ranking
247
National Ranking
166

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in United States Leader Award

Overview

Christopher J. O'Donnell is affiliated with Harvard Medical School in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular focus on Molecular Biology, Oncology, Pharmaceutical Science, Organic Chemistry, and Immunology and Allergy as subfields of study.

The scientist's body of work covers several core topics, including Chemical Reactions and Isotopes, Cell Adhesion Molecules Research, CAR-T cell therapy research, Synthesis and Biological Evaluation, Cellular Mechanics and Interactions, Cerebrovascular and genetic disorders, and Biochemical and Molecular Research.

O'Donnell has authored multiple papers, notably:

  • "Synthetic Approaches to New Drugs Approved during 2018," 2020, Journal of Medicinal Chemistry
  • "PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers," 2020, Molecular Cancer Therapeutics
  • "Synthetic Approaches to the New Drugs Approved during 2019," 2021, Journal of Medicinal Chemistry
  • "Synthetic Approaches to the New Drugs Approved During 2020," 2022, Journal of Medicinal Chemistry
  • "NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells," 2021, Cell Reports Medicine

Frequent co-authors in O'Donnell's publications include:

  • Hans-Peter Gerber
  • Andrew C. Flick
  • Hong X. Ding
  • Emma L. McInturff
  • Sarah J. Fink

Their research appears regularly in certain journals, with five publications in the Journal of Medicinal Chemistry, two in Molecular Cancer Therapeutics, and others in Cell Reports Medicine, Clinical Cancer Research, and the Journal of Thrombosis and Haemostasis.

Best Publications

  • Heart Disease and Stroke Statistics—2008 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

    Wayne Rosamond;Katherine Flegal;Karen Furie;Alan Go

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    David C. Goff;Donald M. Lloyd-Jones;Glen Bennett;Sean Coady

  • Heart Disease and Stroke Statistics—2009 Update

    Donald Lloyd-Jones;Robert Adams;Mercedes Carnethon

  • Heart Disease and Stroke Statistics—2007 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

    Wayne Rosamond;Katherine Flegal;Gary Friday;Karen Furie

  • Heart Disease and Stroke Statistics—2006 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

    Thomas Thom;Nancy Haase;Wayne Rosamond

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda

  • Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

    Caroline S. Fox;Joseph M. Massaro;Udo Hoffmann;Karla M. Pou

  • Metabolite profiles and the risk of developing diabetes

    Thomas J Wang;Martin G Larson;Martin G Larson;Ramachandran S Vasan;Ramachandran S Vasan;Susan Cheng;Susan Cheng;Susan Cheng

  • Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease

    Ramachandran S. Vasan;Martin G. Larson;Eric P. Leip;Jane C. Evans

  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

    David C. Goff;Donald M. Lloyd-Jones;Faha Glen Bennett;Sean Coady

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

    M Nikpay;A Goel;Won H-H.;L M Hall

  • Hundreds of variants clustered in genomic loci and biological pathways affect human height

    Hana Lango Allen;Karol Estrada;Guillaume Lettre;Sonja I. Berndt

  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

    Georg B. Ehret;Georg B. Ehret;Georg B. Ehret;Patricia B. Munroe;Kenneth M. Rice;Murielle Bochud

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Genome-wide association study of blood pressure and hypertension

    Daniel Levy;Georg B. Ehret;Georg B. Ehret;Kenneth Rice;Germaine C. Verwoert

  • A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

    Majid Nikpay;Anuj Goel;Hong-Hee Won;Leanne M. Hall

  • Hundreds of variants clustered in genomic loci and biological pathways affect human height

    H. Lango Allen;K. Estrada;G. Lettre;S. I. Berndt

Frequent Co-Authors

Daniel Levy
Daniel Levy National Institutes of Health
Caroline S. Fox
Caroline S. Fox MSD (United States)
Sekar Kathiresan
Sekar Kathiresan Harvard University
Ramachandran S. Vasan
Ramachandran S. Vasan The University of Texas Health Science Center at San Antonio
Bruce M. Psaty
Bruce M. Psaty University of Washington
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
L. Adrienne Cupples
L. Adrienne Cupples Boston University
Udo Hoffmann
Udo Hoffmann Harvard University
Joseph M. Massaro
Joseph M. Massaro Boston University
Albert Hofman
Albert Hofman Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean a traditional MD. Students interested in healthcare will find a growing number of flexible options to advance or specialize—especially through online study. Online nursing courses offer an accessible route into the nursing profession, with varied programs from ADN to BSN levels to suit your career stage.

For those seeking advanced clinical roles, the most affordable online nurse practitioner programs help registered nurses (RNs) transition to more specialized positions with increased responsibility and pay. Many RNs also look to upgrade their qualifications through the cheapest rn to bsn program online, which gives them a critical edge in the job market.

Ambitious nurses interested in leadership, research, or teaching can consider phd nursing programs online. These programs make progression to the highest levels in nursing more convenient, particularly for working professionals. By selecting affordable and accredited programs, students can expand their skills and open doors to diverse and rewarding opportunities in healthcare.

Best Scientists Citing Christopher J. O'Donnell

Trending Scientists